USPTO serial 78844201
IBIS BIOSCIENCES
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- PILARO, MARK F
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with IBIS BIOSCIENCES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mary L. Winburn
Mary L. Winburn Abbott Laboratories100 Abbott Park RoadD377/AP6AAbbott Park, IL 60064-6008Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Scientific and technological research services in the areas of analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; development for others and leasing to others of biosensor systems for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens, and parts therefor, for scientific and research use; development for others and leasing to others of biosensor systems for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens, and parts therefor, for scientific and research use; development for others and leasing to others of test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for scientific and research use; development for others and leasing to others of test and collection devices and kits for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for scientific and research use; development for others and leasing to others of computer software and hardware for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; development for others and leasing to others of computer software and hardware for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; development for others of biosensor systems for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens, and parts therefor, for medical use; development for others of biosensor systems for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens, and parts therefor, for medical use; development for others of test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for medical use; development for others of test and collection devices and kits for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for medical use | ACTIVE | — |
| 044 | Leasing to others of biosensor systems for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens, and parts therefor, for medical use; leasing to others of biosensor systems for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens, and parts therefor, for medical use; leasing to others of test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for medical use; leasing to others of test and collection devices and kits for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens for medical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Isis Pharmaceuticals, Inc.
- Other trademarks owned by Isis Pharmaceuticals, Inc.
- Other trademarks owned by IBIS BIOSCIENCES, INC.
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named IBIS BIOSCIENCES
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 7, 2010 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 7, 2010 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 4, 2009 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Nov 2, 2009 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 2, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 28, 2009 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 28, 2009 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 10, 2009 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Mar 9, 2009 | EXT2 | SOU EXTENSION 2 FILED | — |
| Mar 9, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 17, 2008 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Nov 7, 2008 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 6, 2008 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 5, 2008 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 5, 2008 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 6, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 12, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 23, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Jan 9, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 9, 2008 | ALIE | ASSIGNED TO LIE | — |
| Nov 21, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 9, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 9, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 9, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 22, 2007 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 22, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 18, 2007 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 5, 2007 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jan 11, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 8, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 4, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 4, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 4, 2007 | ALIE | ASSIGNED TO LIE | — |
| Nov 29, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 6, 2006 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 6, 2006 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Sep 7, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 29, 2006 | NWAP | NEW APPLICATION ENTERED | — |